NEWEarnings

Nurix (NRIX) Stock Price Target Raised to $34 by H.C. Wainwright

Published on 7/10/2026

#NRIX#Earnings
Nurix (NRIX) Stock Price Target Raised to $34 by H.C. Wainwright

AI Summary

Summarized by AI from the source below

H.C. Wainwright has raised its price target for Nurix Therapeutics (NRIX) to $34 per share. This revised target reflects an optimistic view on the company's potential growth and market opportunities. Nurix's stock may react positively as analysts adjust expectations based on recent developments. Investors should note that analysts' price targets can influence trading behavior and market sentiment.

Share:
Source: Read original article (opens in new tab)

Get the free market brief

Top stories and analysis, summarized. No spam, unsubscribe anytime.

Related News

Delta (DAL) Forecasts Q3 Earnings of $2.00 to $2.50 Per Share
Earnings

Delta (DAL) Forecasts Q3 Earnings of $2.00 to $2.50 Per Share

Jul 10

Niagen Bioscience Stock Rating Reiterated by Canaccord Amid Drug Launch
Earnings

Niagen Bioscience Stock Rating Reiterated by Canaccord Amid Drug Launch

Jul 10

PDF Solutions (PDFS) Stock Target Raised on Growth Outlook
Earnings

PDF Solutions (PDFS) Stock Target Raised on Growth Outlook

Jul 10

Ionis (IONS) Stock Price Target Cut to $95 After Trial Results
Earnings

Ionis (IONS) Stock Price Target Cut to $95 After Trial Results

Jul 10